MGNet Administrative Core

MGNet 管理核心

基本信息

批准号：
10207811
负责人：
HENRY J KAMINSKI
金额：
$ 94.96万
依托单位：
GEORGE WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-01 至 2024-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10207811
关键词：
Advertising Americas Award Biometry Clinical Clinical Research Clinical Trials Clinical and Translational Science Awards Collaborations Data Analyses Development Drug Industry Education Financial Support Foundations General Hospitals Goals Health Professional Immunologics Immunologist Individual Industry Information Dissemination Infrastructure Institutional Review Boards International Investigation Leadership Manuscripts Massachusetts Mission Muscular Dystrophies Myasthenia Gravis North Carolina Outcome Measure Patient Care Patient advocacy Patients Performance Pharmacologic Substance Pilot Projects Preparation Process Progress Reports Rare Diseases Recording of previous events Research Research Project Grants Resources Scientist Services Site Strategic Planning Structure Therapeutic Training Universities Validation Virginia Washington career clinical center clinical trial readiness data sharing improved industry partner infrastructure development interest meetings member novel therapeutics patient advocacy group payment predictive marker programs recruit success therapeutic development translational scientist web site

项目摘要

The Administrative Core of MGNet serves to support all activities of the RDCRN to optimize clinical research performance and career enhancement activities. We do so by provision of staff focused on facilitation of all activities related to study initiation, performance, and close out activities. Core services for clinical research coordinator training, biostatistical analysis, clinical trial development, and immunological investigations will be provided. The leadership of MGNet includes the administrative coordinator, clinicians, translational scientists, immunologists, patient advocacy group leadership, and patients. This collaborative group will provide oversight and drive process improvement as well as develop a strategic plan to assure the long-term viability of MGNet. Administrative Core will develop focused projects beyond those in the present proposal to enhance clinical trial readiness beyond MGNet sites and partner with industry to optimize the performance of MG clinical trials. The shared goals of all members of MGNet are 1) to provide a structure to enhance discovery and validation of treatment-responsive or – predictive markers with the ultimate goal of enhancing therapeutic development, 2) improve clinical trial outcome measures and infrastructure, and 3) enhance the quality of clinical research for MG. As MGNet matures, the

MGNet 的管理核心用于支持 RDCRN 的所有活动以优化我们通过提供员工来实现临床研究绩效和职业提升活动。专注于促进与研究启动、执行和结束相关的所有活动临床研究协调员培训、生物统计分析、临床的核心服务。 MGNet 将负责试验开发和免疫学研究。包括行政协调员、退伍军人、转化科学家、免疫学家、患者该协作小组将提供监督和指导。推动流程改进并制定战略计划以确保长期生存能力 MGNet 的管理核心将开发超出目前范围的重点项目。提议加强 MGNet 站点之外的临床试验准备并与行业合作优化 MG 临床试验的表现 MGNet 所有成员的共同目标是 1) 提供一个结构来增强治疗反应的发现和验证或 – 预测标记物的最终目标是促进治疗开发，2) 改善临床试验结果衡量和基础设施，以及 3) 提高临床质量随着 MGNet 的研究逐渐成熟，